PFZ Share Price

Open 34.31 Change Price %
High 34.31 1 Day -0.17 -0.49
Low 34.31 1 Week 0.00 0.00
Close 34.31 1 Month 0.00 0.00
Volume 110 1 Year 1.69 5.18
52 Week High 34.65
52 Week Low 30.00
PFZ Important Levels
Resistance 2 34.31
Resistance 1 34.31
Pivot 34.31
Support 1 34.31
Support 2 34.31
LON UK Most Active Stocks
GGP 2.27 10.19%
GGP 2.27 10.19%
GGP 2.27 10.19%
CWC 74.60 0.27%
CWC 74.60 0.27%
CWC 74.60 0.27%
INC 0.04 -20.00%
FCR 0.07 16.67%
FCR 0.07 16.67%
LLOY 67.00 0.01%
More..
LON UK Top Gainers Stocks
AKT 28.50 5177.78%
HHR 58.00 900.00%
MLD 10.00 700.00%
MES 0.28 75.00%
MES 0.28 75.00%
MES 0.28 75.00%
PFLM 5.75 64.29%
BAC 22.54 61.00%
BAC 22.54 61.00%
BAC 22.54 61.00%
More..
LON UK Top Losers Stocks
ENDV 0.02 -99.85%
KEA 0.10 -91.30%
ACU 0.05 -87.50%
ACU 0.05 -87.50%
ACU 0.05 -87.50%
DCP 0.50 -75.61%
PCI 3.50 -53.27%
PCI 3.50 -53.27%
BHR 0.02 -33.33%
NBR 0.25 -24.24%
More..

Pfizer Inc (LON: PFZ)

PFZ Technical Analysis 2.5
As on 22nd Mar 2017 PFZ Share Price closed @ 34.31 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 722.08 & Strong Buy for SHORT-TERM with Stoploss of 33.10 we also expect STOCK to react on Following IMPORTANT LEVELS.
PFZ Target for October
1st Target up-side N/A
2nd Target up-side N/A
3rd Target up-side N/A
1st Target down-side N/A
2nd Target down-side N/A
3rd Target down-side N/A
PFZ Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Drug Manufacturers - Major
Offical website http://www.pfizer.com
PFZ Address
PFZ
235 East 42nd Street
New York, NY 10017
United States
Phone: 212-733-2323
PFZ Latest News
Interactive Technical Analysis Chart Pfizer Inc ( PFZ LON UK )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Pfizer Inc
PFZ Business Profile
Pfizer Inc., a biopharmaceutical company, discovers, develops, manufactures, and sells healthcare products worldwide. Its product portfolio includes medicines and vaccines, as well as various consumer healthcare products. The company’s Primary Care segment offers prescription pharmaceutical products primarily prescribed by primary-care physicians for various therapeutic and disease areas comprising Alzheimer’s disease, cardiovascular, erectile dysfunction, genitourinary, major depressive disorder, pain, respiratory, and smoking cessation. Its Specialty Care and Oncology segment provides prescription pharmaceutical products for anti-infectives, endocrine disorders, hemophilia, inflammation, ophthalmology, pulmonary arterial hypertension, specialty neuroscience, and vaccines, as well as oncology and oncology-related illnesses. The company’s Established Products and Emerging Markets segment offers prescription pharmaceutical products that had lost patent protection or marketing exclusivity in certain countries and/or regions, as well as sold in emerging markets, including Asia, Latin America, the Middle East, Eastern Europe, Africa, Turkey, and Central Europe. Its Consumer Healthcare segment provides non-prescription products in a range of therapeutic categories, such as dietary supplements, pain management, respiratory, and personal care. The company primarily offers biopharmaceutical products, including Lyrica, the Prevnar family of products, Enbrel, Celebrex, Lipitor, Viagra, Zyvox, Norvasc, Sutent, and the Premarin family of products; and consumer healthcare products under the Advil, Caltrate, Centrum, ChapStick, Emergen-C, Preparation H, and Robitussin brands. It sells its products to wholesalers, distributors, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, and grocery and convenience stores. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.